Mark Dayan
Mark Dayan is a policy analyst at the Nuffield Trust, where he leads the Brexit programme. He has been vocal about the significant impact of Brexit on the UK's medicine supply chain, highlighting that recent shortages of vital medications, such as those for epilepsy and cystic fibrosis, are a growing concern for patient health.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Mark Dayan, the Brexit programme lead at the Nuffield Trust, highlighted the disruptions caused by Brexit on health and research.
6
United Kingdom:
Mark Dayan, a policy analyst at the Nuffield Trust, highlighted the worrying wave of medicine shortages affecting patients.
6